Product Classification
- drug impurity
- drug standards
- Metaraminol bitartrate
- analytical chemistry
- standard substances
- chemical custom synthesis
- Azithromycin
- Atorvastatin
- (S)-Cinacalcet
- Ilaprazole
- Tranexamic Acid
- Duloxetine
- Octreotide
- Budesonide
- Carboprost Trometamol
- Minocycline
- Dobutamine
- Netupitant
- Axitinib
- Omadacycline
- Brivaracetam
- Metoprolol
- Indobufen
- Empagliflozin
- Dapagliflozin
- Acetylcysteine
- Hydroxychloroquine
- Tegoprazan
- Lenalidomide
- Canagliflozin
- Bromocriptine
- Rasagiline
- Bortezomib
- Diclofenac
- Bisoprolol
- Rocuronium Bromide
- Esmolol
- Bromhexine
- Probucol
- Formoterol
- Crisaborole
- Pitavastatin (3S,5S)-Isomer Calcium
- Bumetanide
- Dotinurad
- Fulvestrant
- Dotinurad
- Landiolol
Contact us
Tel：+86 17320513646
Phone：+86 17320513646
Website：https://www.moxinchem.com
Email： mike@molcoo.com
Address：Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
69630-16-6
- Product Name：Landiolol impurity
- Molecular Formula：C7H15N3O2
- Purity：99%
- Molecular Weight：173.215
Product Details;
CasNo： 69630-16-6
Molecular Formula： C7H15N3O2
Manufacturer supply high quality Landiolol impurity 69630-16-6 with GMP standards
- Molecular Formula:C7H15N3O2
- Molecular Weight:173.215
- PSA：67.59000
- LogP:0.01600
69630-16-6 Relevant articles
Preparation method of landiolol hydrochloride
-
Paragraph 0063-0065, (2018/11/22)
The invention relates to a preparation m...
Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders
Yi, Bitna,Jahangir, Alam,Evans, Andrew K.,Briggs, Denise,Ravina, Kristine,Ernest, Jacqueline,Farimani, Amir B.,Sun, Wenchao,Rajadas, Jayakumar,Green, Michael,Feinberg, Evan N.,Pande, Vijay S.,Shamloo, Mehrdad
, (2017/08/01)
The beta-1 adrenergic receptor (ADRB1) i...
Preparation method of landiolol hydrochloride
-
, (2017/08/14)
The invention provides a preparation met...
METHOD OF IMPROVING COGNITION AND SOCIAL BEHAVIOR IN HUMANS HAVING DEFICITS THEREIN DUE TO NEURODEGENERATIVE DISORDERS AND COMPOUNDS AND COMPOSITIONS THEREFOR
-
, (2016/08/03)
A β1-ADR agonist prodrug compound, which...
69630-16-6 Process route
-
-
215654-61-8
tert-butyl 2-(3-(morpholine-4-carboxamido)ethyl)carbamate
-
-
69630-16-6
N-(2-aminoethyl)-4-morpholine carboxamide
| Conditions | Yield |
|---|---|
|
With
trifluoroacetic acid;
In
dichloromethane;
at 20 ℃;
|
100% |
|
With
trifluoroacetic acid;
In
dichloromethane;
at 0 ℃;
for 1.5h;
|
91% |
|
With
trifluoroacetic acid;
In
dichloromethane;
at 0 ℃;
for 1.5h;
|
91% |
-
-
154467-16-0,947674-94-4
N-(2-aminoethyl)-4-morpholine carboxamide oxalic acid
-
-
69630-16-6
N-(2-aminoethyl)-4-morpholine carboxamide
| Conditions | Yield |
|---|---|
|
With
sodium sulfate; sodium hydroxide;
In
dichloromethane;
at 30 ℃;
Large scale;
|
99.5% |
|
With
sodium hydroxide;
In
water;
at 20 - 47 ℃;
for 0.333333h;
pH=10-11.5;
|
84.67% |
69630-16-6 Upstream products
-
93605-74-4
4-[(1H-imidazol-1-yl)carbonyl]morpholine
-
107-15-3
ethylenediamine
-
15159-40-7
4-morpholinocarbonyl chloride
-
215654-61-8
tert-butyl 2-(3-(morpholine-4-carboxamido)ethyl)carbamate
69630-16-6 Downstream products
-
136610-16-7
methyl 3-methoxy-4-<3-<2-(morpholinocarbonylamino)ethylamino>-2S-hydroxypropoxy>phenylpropiolate
-
136610-12-3
[4-(2-Hydroxy-3-{2-[(morpholine-4-carbonyl)-amino]-ethylamino}-propoxy)-phenyl]-propynoic acid methyl ester
-
136610-14-5
[4-((S)-2-Hydroxy-3-{2-[(morpholine-4-carbonyl)-amino]-ethylamino}-propoxy)-phenyl]-propynoic acid methyl ester
-
133242-62-3
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-[4-[2-hydroxy-3-(2-morpholinocarbonylaminoethyl)aminopropoxy]phenyl]propionate
Related products
-
(R,S)-Palonosetron HClDetail
CAS:135755-51-0
$ -
(S,R)-Palonosetron HClDetail
CAS:135729-76-9
$ -
Dotinurad ImpurityDetail
CAS:1285572-54-4
$ -
(R,S)-Palonosetron HClDetail
CAS:135755-51-0
$
